Pupillary Unrest in Ambient Light, and Relationship to Opioid-Induced Respiratory Depression
Completed · Phase 1
Conditions studied: Opioid; Intoxication, Perception Disturbance (Acute), Acute Pain, Overdose of Opiate, Respiratory Depression, Safety Issues
In brief
Volunteers will receive a weight-based opioid (remifentanil) infusion for 10 minutes. In the first run, serial pupillary measurements (pupillary unrest, pupil diameter) will be taken at baseline, and at 2.5-minute intervals during the infusion and a 25-minute recovery period afterwards. After a washout period, the experiment will be repeated in each subject (second run). The two runs differ only by presence versus absence of verbal interaction.
Key facts
- Study ID
- NCT04301895
- Run by
- University of California, San Francisco
- People needed
- 20
- Starts
- 2019-04-30
- Expected to finish
- 2019-09-03
- Last updated by the study team
- 2020-03-10
Who can join
Age: 20 and older, up to 55. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Healthy
- Able to provide informed consent
You may not qualify if…
- Active substance use disorder
- Prior opioid use disorder
- Opioid use within 30 days.
Where it is running
- University of California San Francisco — San Francisco, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.